Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2015 Mar 1.

Published in final edited form as: Ann Allergy Asthma Immunol. 2014 Jan 7;112(3):211–216.e1. doi: 10.1016/j.anai.2013.12.006

Table 2.

Expansion of CD4+ and CD8+ T Cells and the Effect of DEX Treatment

Group	CD4⁺ T cells		CD8⁺ T cells
Group	Total cell count (x10⁶) (mean±SD)	% Reduction of Cell Expansion	Total cell count (x10⁶) (mean±SD)	% Reduction of Cell Expansion
CTL Dex(−)	24.4±11.7		31.7±14.8
CTL Dex(+)	8.5±8.6^*	65%	16.0±8.2^*	50%
SS Dex(−)	38.4±22.1		44.1±26.0
SS Dex(+)	7.8±4.4^*	80%	25.5±15.5^*	60%
SR Dex(−)	16.3±9.0		21.4±5.5
SR Dex(+)	3.3±1.9^*	80%	17.6±5.3^NS	19%^#

^*

P<0.05 compared to non-DEX-treated group.

^#

P<0.05 compared to CTL and SS groups.

NS: Not significant.